Dr. Fouad M. Hajjar
Claim this profileAdventHealth Orlando
Expert in Tumors
Expert in Brain Tumor
40 reported clinical trials
81 drugs studied
About Fouad M. Hajjar
Education:
- Obtained MD from the American University of Beirut Faculty of Medicine, Lebanon, in 1987.
- Completed Residency in Internal Medicine at the University of Florida College of Medicine, Gainesville, FL, in 1990.
- Finished Fellowship in Cardiovascular Disease at the University of Florida College of Medicine, Gainesville, FL, in 1993.
Experience:
- Currently serves as a cardiologist at AdventHealth Orlando.
- Holds a position as an Assistant Professor of Medicine at the University of Central Florida College of Medicine.
Area of expertise
1Tumors
Global LeaderStage I
Stage II
Stage IV
2Brain Tumor
Global LeaderStage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Fouad M. Hajjar is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Fouad M. Hajjar
Clinical Trial Related7 years of experience running clinical trials · Led 40 trials as a Principal Investigator · 14 Active Clinical TrialsTreatments Fouad M. Hajjar has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Methotrexate
- Vincristine Sulfate
- Cytology Specimen Collection Procedure
Breakdown of trials Fouad M. Hajjar has run
Tumors
Brain Tumor
Neuroblastoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Fouad M. Hajjar specialize in?
Fouad M. Hajjar focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage II.
Is Fouad M. Hajjar currently recruiting for clinical trials?
Yes, Fouad M. Hajjar is currently recruiting for 10 clinical trials in Orlando Florida. If you're interested in participating, you should apply.
Are there any treatments that Fouad M. Hajjar has studied deeply?
Yes, Fouad M. Hajjar has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Fouad M. Hajjar?
Apply for one of the trials that Fouad M. Hajjar is conducting.
What is the office address of Fouad M. Hajjar?
The office of Fouad M. Hajjar is located at: AdventHealth Orlando, Orlando, Florida 32803 United States. This is the address for their practice at the AdventHealth Orlando.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.